Single doses of ivermectin 400 micrograms/kg-1: the most effective dosage in bancroftian filariasis.
Forty-three Wuchereria bancrofti carriers were given four successive semi-annual single doses of ivermectin 100 micrograms.kg-1 (IVER 100). The geometric mean microfilaremia (mf) recurrence percentage as compared to the pre-initial treatment mf level was 35%, 21%, 17% and 17% at 6, 12, 18 and 24 months, respectively. However, the recurrence of mf 6 months after the fourth treatment remained high in several individuals: 15 have been considered as 'bad responders' and 28 as 'good responders' individuals. At month 24 (M 24), they were randomly allocated into 2 groups. A first group was treated with a fifty and a sixth dose of IVER 100, at M24 and M30, respectively; the second one was treated, at the same time, with single doses of IVER 400 micrograms.kg-1 (IVER 400). At M 36, the mf recurrence percentage (mf M36/mf M0) was significantly higher in patients treated with IVER 100 than IVER 400 (11% vs 1%, p < 10(-4). From the group IVER 100, 6 out of the 8 'bad responders' remained 'bad responders' whereas there were none of the 7 in the group IVER 400. Moreover, there were only 2 more patients in the group IVER 100 showing sustained complete zero mf, whereas they were 13 in the group IVER 400. Single doses of IVER 400 were effective on 'bad responders'; IVER 400 must be recommended for semi-annual mass treatment in bancroftian filariasis.
Institut Territorial de Recherches Médicales Louis Malardé, Papeete, Tahiti, French Polynesia.
J P
JP
Moulia-Pelat
P
P
Glaziou
L N
LN
Nguyen
J L
JL
Cartel
D000328:Adult; D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D004605:Elephantiasis, Filarial / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage*; D008875:Middle Aged; D011114:Polynesia; D012008:Recurrence; D014958:Wuchereria bancrofti
D000969:Antinematodal Agents; D007559:Ivermectin